Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.

Ligorio F, Provenzano L, Fotia G, Dieci MV, Curigliano G, Giuliano M, Botticelli A, Lambertini M, Rizzo G, Pedersini R, Sirico M, La Verde N, Gennari A, Zambelli A, Toss A, Piras M, Giordano M, Tagliaferri B, Generali D, Sartori D, Mazzoli G, Jacobs F, Armani G, Sposetti C, Zurlo C, Menichetti A, Griguolo G, Faso V, Boldrini L, Munzone E, Marra A, Chiappe E, Scagnoli S, Pisegna S, Capasso C, De Angelis C, Arpino G, Criscitiello C, Guarneri V, Pruneri G, Mariani L, PALMARES-2 study group, Vernieri C

Open source

DOI
10.1016/j.breast.2026.104769
Published
2026 Jun
Container
Breast (Edinburgh, Scotland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.breast.2026.104769,
  title = {Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.},
  author = {Ligorio F and Provenzano L and Fotia G and Dieci MV and Curigliano G and Giuliano M and Botticelli A and Lambertini M and Rizzo G and Pedersini R and Sirico M and La Verde N and Gennari A and Zambelli A and Toss A and Piras M and Giordano M and Tagliaferri B and Generali D and Sartori D and Mazzoli G and Jacobs F and Armani G and Sposetti C and Zurlo C and Menichetti A and Griguolo G and Faso V and Boldrini L and Munzone E and Marra A and Chiappe E and Scagnoli S and Pisegna S and Capasso C and De Angelis C and Arpino G and Criscitiello C and Guarneri V and Pruneri G and Mariani L and PALMARES-2 study group and Vernieri C},
  year = {2026},
  journal = {Breast (Edinburgh, Scotland)},
  doi = {10.1016/j.breast.2026.104769},
  url = {https://doi.org/10.1016/j.breast.2026.104769}
}

RIS

TY  - JOUR
TI  - Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.
AU  - Ligorio F
AU  - Provenzano L
AU  - Fotia G
AU  - Dieci MV
AU  - Curigliano G
AU  - Giuliano M
AU  - Botticelli A
AU  - Lambertini M
AU  - Rizzo G
AU  - Pedersini R
AU  - Sirico M
AU  - La Verde N
AU  - Gennari A
AU  - Zambelli A
AU  - Toss A
AU  - Piras M
AU  - Giordano M
AU  - Tagliaferri B
AU  - Generali D
AU  - Sartori D
AU  - Mazzoli G
AU  - Jacobs F
AU  - Armani G
AU  - Sposetti C
AU  - Zurlo C
AU  - Menichetti A
AU  - Griguolo G
AU  - Faso V
AU  - Boldrini L
AU  - Munzone E
AU  - Marra A
AU  - Chiappe E
AU  - Scagnoli S
AU  - Pisegna S
AU  - Capasso C
AU  - De Angelis C
AU  - Arpino G
AU  - Criscitiello C
AU  - Guarneri V
AU  - Pruneri G
AU  - Mariani L
AU  - PALMARES-2 study group
AU  - Vernieri C
PY  - 2026
JO  - Breast (Edinburgh, Scotland)
DO  - 10.1016/j.breast.2026.104769
UR  - https://doi.org/10.1016/j.breast.2026.104769
ER  -

APA

F, L., L, P., G, F., MV, D., G, C., M, G., A, B., M, L., G, R., R, P., M, S., N, L. V., A, G., A, Z., A, T., M, P., M, G., B, T., D, G., D, S., G, M., F, J., G, A., C, S., C, Z., A, M., G, G., V, F., L, B., E, M., A, M., E, C., S, S., S, P., C, C., C, D. A., G, A., C, C., V, G., G, P., L, M., group, P. S., & C, V. (2026). Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2026.104769

Source records